MEGAN FLOTT: Open Payments
NPI 1194051508 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,457 in 227 payments from 20 companies in 2025. Trend: 2023 $3,360 · 2024 $3,200 · 2025 $3,457
Food & beverage: $3,457
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 31 | $538 |
| ABBVIE INC. | 60 | $454 |
| Otsuka America Pharmaceutical, Inc. | 20 | $397 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $394 |
| Neurocrine BioSciences, Inc. | 14 | $303 |
| Vanda Pharmaceuticals Inc. | 13 | $213 |
| E.R. Squibb & Sons, L.L.C. | 14 | $204 |
| Axsome Therapeutics, Inc. | 17 | $190 |
| Lundbeck LLC | 10 | $165 |
| Janssen Pharmaceuticals, Inc | 7 | $154 |
Products named: AUSTEDO XR, REXULTI, VRAYLAR, CAPLYTA, INGREZZA, FANAPT, COBENFY, Auvelity.
Industry payments across NC — which companies pay providers there.
